Dosing Guide
Mounjaro Dose Schedule Guide: Understanding Every Dose Step
Quick Answer: Mounjaro treatment begins at 2.5 mg once weekly and increases every four weeks through 5 mg, 7.5 mg, 10 mg and 12.5 mg before reaching the maximum maintenance dose of 15 mg at approximately week 21. The gradual escalation is designed to reduce side effects and allow the body to adapt to tirzepatide's dual GLP-1/GIP mechanism. Not all patients need to reach 15 mg — some maintain excellent results at 10 mg or 12.5 mg. All doses are administered as a once-weekly subcutaneous injection.6 stepsin the Mounjaro dose escalation schedule
20 weeksto reach 15 mg maintenance dose
15 mgmaximum licensed maintenance dose — best efficacy
Why Doses Increase Gradually
Why Mounjaro's Escalation Schedule Matters
Mounjaro does not begin at its full therapeutic dose. The six-step escalation spanning approximately 20 weeks is a core feature of tirzepatide's clinical design — not simply a formality. Without it, the full GI impact of tirzepatide at therapeutic concentrations would be experienced immediately, producing severely elevated rates of nausea, vomiting and diarrhoea. GLP-1 and GIP receptors also partially down-regulate their sensitivity in response to sustained agonism — a biological adaptation that reduces side effect intensity over time. Completing the full escalation and reaching 15 mg produces the greatest clinical outcomes: SURMOUNT-1 shows 22.5% average weight loss at 15 mg versus 19.5% at 10 mg.
Full Dose Escalation Chart
| Dose | Timeline | Purpose | Side Effects | Key Advice | Status |
|---|---|---|---|---|---|
| 2.5 mg | Weeks 1–4 | Tolerability dose | Mild nausea possible | Do not increase early | Escalation |
| 5 mg | Weeks 5–8 | First escalation | Nausea may increase; diarrhoea common | Monitor GI tolerance | Escalation |
| 7.5 mg | Weeks 9–12 | Second escalation | Peak nausea period | Eat smaller meals | Escalation |
| 10 mg | Weeks 13–16 | Third escalation | GI settling for most | Appetite markedly reduced | Escalation |
| 12.5 mg | Weeks 17–20 | Fourth escalation | Nausea reducing | Body well-adapted | Escalation |
| 15 mg | Week 21+ | Maintenance | Side effects settle | Maximum licensed dose | Maintenance |
Important: The schedule above represents the standard clinical protocol. Your prescribing clinician may recommend a modified schedule — for example, spending six or eight weeks at each step — based on your individual tolerance. Always follow the schedule agreed with your Happy Pharmacy prescribing team.
Dose by Dose
What to Expect at Each Dose Step
2.5 mg — Starting Dose
Most patients tolerate the starting dose well. Mild nausea may occur around injection day. Weight loss is typically modest (1–3 kg) — the primary goal at this stage is adaptation, not maximal efficacy. Many patients are surprised to notice meaningful appetite reduction even at this dose within the first two weeks. Do not attempt to escalate early, even if the starting dose feels minimal.
5 mg — First Escalation
GLP-1 and GIP receptor stimulation increases meaningfully. Nausea is more commonly reported and diarrhoea is frequent in the first one to two weeks. Most patients find symptoms manageable within two weeks. Weight loss accelerates — patients begin to notice reduced portion sizes and decreased interest in snacking. Stay well hydrated — diarrhoea at this step increases dehydration risk.
7.5 mg — Second Escalation
The dose at which many patients experience their highest side effect burden. Constipation often emerges alongside any remaining diarrhoea as gastric emptying slows further. Appetite suppression becomes clinically significant. Clinical data consistently shows that patients who continue past the 7.5 mg step go on to achieve the best long-term outcomes — side effects here are transient.
10 mg — Third Escalation
For many patients, the 10 mg step is noticeably more comfortable than 7.5 mg. Side effects are typically settling and the body is increasingly adapted to tirzepatide's dual mechanism. Significant weight loss acceleration is common at this dose — appetite suppression is near its maximum. Maintain adequate protein intake (aim for 1.2 g/kg body weight daily) to preserve lean muscle mass.
12.5 mg — Fourth Escalation
Most patients find this step significantly easier than the 7.5 mg or 10 mg steps. Near-maximum weight loss efficacy is achieved — average weight loss at 12.5 mg over 72 weeks was approximately 20.9% in SURMOUNT-1. Use this step to embed dietary and exercise habits that will sustain weight loss at maintenance, particularly resistance training to preserve lean muscle mass.
15 mg — Maintenance Dose
For most patients, side effects at 15 mg are substantially reduced compared to the escalation phase. SURMOUNT-1 data shows 22.5% average weight loss at 15 mg over 72 weeks — the highest weight loss efficacy of any dose in the Mounjaro schedule. NICE TA1026 and the Mounjaro SmPC position tirzepatide as a long-term treatment — there is no evidence of therapeutic tolerance developing at 72 weeks.
Clinical Outcomes
Weight Loss at Each Maintenance Dose
| Maintenance Dose | Avg Weight Loss (SURMOUNT-1, 72 wks) | Typical Patient Profile |
|---|---|---|
| 10 mg | ~19.5% | Patients who experience intolerable side effects at higher doses; good responders who achieve goal weight at this level |
| 12.5 mg | ~20.9% | Near-maximum efficacy with better tolerability for some; patients who cannot tolerate 15 mg |
| 15 mg | ~22.5% | Standard maintenance target; recommended for all patients who can tolerate full escalation |
Not All Patients Reach 15 mg — and That Is Clinically Acceptable: A patient who achieves and maintains 19.5% weight loss at 10 mg has achieved an exceptional outcome. The goal is the highest tolerated dose producing sustained benefit. For most patients experiencing intolerable side effects, a slower escalation schedule — spending six or eight weeks at each step — is better than permanently staying at a sub-maximum dose.
Missed Dose Guide
| Scenario | What to Do |
|---|---|
| Missed dose — 4 days or fewer have passed | Take the missed dose as soon as you remember. Resume your usual weekly injection day going forward. |
| Missed dose — more than 4 days have passed | Skip the missed dose entirely. Take your next dose on your usual scheduled day. Do not double up. |
| Missed multiple doses (1–2 weeks) | Resume on your normal schedule. Expect a temporary return of side effects. Contact Happy Pharmacy for guidance. |
| Extended break (4+ weeks) | Do not restart at your previous dose. Contact your prescribing clinician — a dose reduction and re-escalation is required. |
Important: Mounjaro has a shorter half-life (~5 days) than Wegovy (~7 days), meaning blood concentrations fall more quickly between injections. Maintaining a consistent weekly injection schedule is particularly important for sustained appetite suppression.
Practical Tip: Set a recurring weekly reminder on your phone for your Mounjaro injection day. If travelling across time zones, maintain the injection day as per UK time or discuss with your Happy Pharmacy team what adjustment is appropriate.
FAQs
Frequently Asked Questions: Mounjaro Dose Schedule
Mounjaro treatment begins at 2.5 mg once weekly for four weeks, then increases every four weeks through 5 mg, 7.5 mg, 10 mg and 12.5 mg before reaching the maximum maintenance dose of 15 mg at approximately week 21. All doses are administered as a once-weekly subcutaneous injection.
The starting dose of Mounjaro is 2.5 mg once weekly. This is a tolerability dose designed to introduce tirzepatide's dual GLP-1/GIP mechanism gradually, allowing the body to adapt before escalation begins. It is taken for the first four weeks of treatment.
The maximum licensed dose of Mounjaro is 15 mg once weekly. This is also the standard maintenance dose target and produces the highest average weight loss — approximately 22.5% of body weight over 72 weeks in SURMOUNT-1.
No. The four-week intervals between dose increases are clinically necessary for receptor adaptation. Escalating faster significantly raises the risk of severe nausea, vomiting and dehydration. If you feel the current dose is having minimal effect, continue as scheduled — the full therapeutic effect builds across the entire escalation period.
Yes — remaining at 10 mg or 12.5 mg is clinically acceptable when 15 mg causes intolerable side effects despite dietary management. Both doses produce clinically meaningful weight loss. However, a slower escalation schedule — spending six or eight weeks at each step — is usually preferable to permanently staying below maximum dose.
If four or fewer days have passed since your missed dose, take it as soon as you remember and resume your usual weekly day. If more than four days have passed, skip the missed dose and take your next dose on your usual scheduled day. For extended breaks of four weeks or more, contact your Happy Pharmacy prescribing team before restarting, as a dose reduction and re-escalation may be required.
Mounjaro has a six-step escalation schedule over 20 weeks (2.5 mg to 15 mg), while Wegovy has a four-step schedule over 16 weeks to 2.4 mg, with a further optional step to 7.2 mg. Mounjaro takes longer to reach maintenance but produces higher average weight loss.
Yes. Mounjaro pens must be stored between 2°C and 8°C — typically in the main body of a household refrigerator, not the freezer or door. Once removed from the refrigerator, a Mounjaro pen can be kept at room temperature (up to 30°C) for up to 30 days. Happy Pharmacy dispatches all Mounjaro orders in validated cold-chain packaging.
Ready to Start Mounjaro Treatment?
GPhC-registered pharmacy (No. 9012585) · UK-licensed prescribers · Free online assessment · Superintendent Pharmacist: Palvinder Deol · Trustpilot 4.8 ★
Browse Mounjaro Doses →
Jastreboff AM et al. SURMOUNT-1. N Engl J Med. 2022;387:205–216. SURMOUNT-2. Lancet. 2023. Mounjaro SmPC. Eli Lilly. 2023. NICE TA1026. 2024. Happy Pharmacy (GPhC No. 9012585). Educational purposes only.